Alterity Therapeutics CEO Dr David Stamler joins Homodeus Research to discuss ATH434, the FDA pathway to Phase 3, the company's approach to treating Multiple System Atrophy (MSA), and the long-term commercial opportunity in neurodegenerative disease.
Craig Mason, Executive Chair of Complii FinTech (ASX:CF1), joins Homodeus Research to discuss the company's AI-powered capital markets software platform, recurring SaaS strategy and long-term vision to become the operating system for Australia's financial services industry.
Alma Metals Managing Director Frazer Tabeart joins Homodeus Research to discuss the Briggs Copper Project, one of Queensland's largest undeveloped copper resources, and the company's strategy to advance it through drilling, engineering studies and future development.
Way2VAT CEO Amos Simantov joins Homodeus Research to discuss how AI is transforming global tax compliance through VAT reclaim automation, e-invoicing and enterprise TaxTech solutions, while outlining the company’s long-term SaaS growth strategy.
McLaren Minerals’ CEO discusses the company’s large-scale titanium project, the growing importance of heavy mineral sands, progress toward development, and why titanium could become an increasingly important critical mineral for global industry.
Freelancer CFO Dylan Carter joins Homodeus Research to discuss the impact of AI on the freelance economy, the growth potential of Escrow.com and Loadshift, and why Freelancer is positioning itself for the next phase of digital commerce.
Butn CEO Rael Ross joins Homodeus Research to discuss embedded finance, the company’s partnership with MYOB, the future of SME lending, and how technology is transforming access to business funding across Australia.
Vmoto Managing Director Ivan Teo joins Homodeus Research to discuss the company's global electric mobility strategy, partnerships with Uber and Ducati, MotoGP branding, and why electric motorcycles are poised for long-term growth.
Havilah Resources (ASX:HAV) Managing Director Dr Chris Giles joins Homodeus Research to discuss the company's exploration strategy, flagship copper and gold projects, partnerships with Sandfire and Hillgrove, and the long-term outlook for critical minerals in South Australia.
Union Star Metals CEO Lucas Stanfield explains the company's strategic transformation, the investment opportunity at Nevada's Cobb Creek Gold Project, and why upcoming drilling could be a pivotal catalyst for the ASX-listed explorer.
Wei Sim interviews Dr Krista Davies, COO of Prominence Energy (ASX:PRM), discussing the investment case for helium and natural hydrogen, Australia's emerging exploration opportunity, Prominence's South Australian projects and the key milestones investors should watch over the coming months.
Firebird Metals Managing Director Ron Mitchell joins Wei Sim to explain why LMFP battery chemistry could become one of the next major innovations in electric vehicles. The discussion explores battery technology, cost advantages, commercialisation plans, and the catalysts that could shape Firebird's future.
Andrew Schwartz, Group Managing Director of Qualitas (ASX: QAL), joins Homodeus Research to unpack the structural bank retreat from real estate financing, the group's new European platform, its AI-enabled credit engine, and what recent Budget tax changes mean for the sector.
Manhattan Gold's GM Bay Rezos walks through the company's first modern drill campaign in 30 years at Hook Lake, Nunavut — 4,000m targeting JAWS, two virgin orogenic gold prospects, a BIF target, and a high-grade VMS deposit. Plus: Arctic geopolitics, Inuit community relations, and the path to 2027.
Teri Thomas, CEO of ASX-listed Mach7 Technologies, joins Wei Sim to unpack the company's turnaround, its vendor-neutral imaging platform, and why solving healthcare's "data plumbing problem" is the unlock that makes AI in radiology actually work.
A semiconductor industry deep dive with chip specialist YT Boon (ex-Arm, Cadence, Broadcom, TSMC, Huawei) on AI capex, the slowdown of Moore's Law, and the resurgence of materials innovation in advanced packaging — with supply-side commentary from Rob Williamson, MD of Alpha HPA (ASX: A4N).
Alpha HPA MD Rob Williamson on the $1B ASX company manufacturing high-purity alumina for TSMC's supply chain, why it undercuts Japanese incumbents on cost, and how it solves the heat problem in advanced AI chips.
Canadian Phosphate discusses why phosphate is becoming strategically important across food security, LFP battery supply chains and geopolitics, while outlining its North American phosphate projects and development plans.
Homodeus Research hosts Greenwing Resources (ASX: GW1) Managing Director Peter Wright for a deep dive into the company's three-pronged critical minerals strategy — and an unexpected data centre opportunity emerging in Tasmania. With a ~$40M market cap, ~$3M cash and no debt, Greenwing is positioning for a critical minerals recovery after a humbling few years in lithium and graphite. Peter lays out the supply/demand dislocation he sees building, why he thinks the market is mispricing the long-term thesis, and how the team plans to unlock value across all three assets in 2026. In this episode: -
Dr Anthony Noble, Executive Chairman of Xenitra Group (ASX: XEN), on the company's turnaround from AUMake, its China FMCG and OTC medicine channels, and the OPAL real-world-asset tokenisation platform.
Provaris Energy CEO Martin Carolan on proprietary tanks for shipping hydrogen and CO2, a capital-light IP-licensing model, Europe's supply deficit into the 2030s, and the catalysts that could re-rate this ASX micro-cap.
Avecho Biotechnology (ASX: AVE) CEO Dr Paul Gavin on the company's CBD insomnia capsule, its TPM absorption technology, the Sandoz licensing deal, the TGA over-the-counter opportunity, and a pivotal Phase 3 interim analysis due in weeks. General info only, not financial advice.
Metals Australia CEO Paul Ferguson on the Lac Carheil graphite project, its Quebec anode refinery, and how MLS stacks up against Nouveau Monde.
40% antimony at surface. Red Mountain Mining's (ASX:RMX) flagship Armidale Antimony-Gold Project in NSW begins its maiden drill program this quarter — 2,000m across up to 20 holes, targeting five priority anomalies. Wei Sim sits down with Nic Matich, Director of Corporate Development at Red Mountain Mining, to walk through the antimony thesis: the commodity, the projects, the jurisdictions, and the timing.
